IQVIA Holdings | IQV - Selling And Administration Expenses



IQVIA Holdings reported $509M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Accenture USD 2.84B 113.59M May/2025
Adcock Ingram Holdings ZAR 1.05B 50.17M Dec/2024
Agilent USD 417M 37M Jul/2025
Bruker USD 231.4M 6M Jun/2025
Cardinal Health USD 1.48B 169M Jun/2025
Celltrion KRW 276.8B 58.09B Mar/2025
Charles River Laboratories USD 185.82M 8.02M Jun/2025
Cigna USD 3.43B 564M Jun/2025
Cognizant Technology Solutions USD 810M 19M Jun/2025
Cspc Pharmaceutical CNY 1.89B 347.81M Mar/2025
CVS Health USD 10.52B 22M Dec/2024
Danaher USD 2.36B 502M Jun/2025
Dentsply International USD 334M 23M Jun/2025
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Divis Laboratories Ltd 3.4B 10M Jun/2025
Elevance Health USD 10.24B 46M Jun/2025
Hologic USD 251.3M 15.1M Jun/2025
Humana 3.36B 614M Mar/2025
IBM USD 4.99B 254M Jun/2025
Illumina USD 234M 13M Jun/2025
Infosys INR 10.77B 27.51B Jun/2025
Kangmei Pharma CNY 259.36M 49.8M Jun/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 579.3M 33.3M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 2.2B 222M Jun/2025
Mettler Toledo International USD 247.3M 4.5M Jun/2025
Organigram Holdings CAD 25.49M 8.3M Jun/2025
Pharma Mar EUR 14.68M 1M Jun/2025
Publicis EUR 4.73B 412M Dec/2024
Qiagen NV USD 148.74M 10.8M Jun/2025
Quest Diagnostics USD 486M 10M Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Sartorius EUR 225.2M 6.7M Jun/2025
Sino Biopharmaceutical CNY 5.31B 1.54B Dec/2024
Thermo Fisher Scientific USD 1.78B 58M Jun/2025
Tilray USD 72.38M 4.99M Nov/2024
UnitedHealth USD 13.59B 1.1B Mar/2025
Veeva Systems USD 118.78M 48.67M Jul/2025
Waters USD 201.26M 26.38M Jun/2025
Zz Pientze Pharmaceu -171290000 342.58M Jun/2025